What Dynex Technologies does

Dynex Technologies, Inc. is a privately held US medical-device manufacturer founded in 1950 and headquartered in Chantilly, Virginia, that designs and produces fully automated ELISA and chemiluminescence microplate workstations, associated proprietary consumables, and supporting software for clinical diagnostic, pharmaceutical research, and specialty testing laboratories. The company sells a three-tier instrument family — the DS2 ELITE (2-plate), DSX (4-plate), and AGILITY (12-plate) — built on an open-platform architecture that supports more than 1,000 established assay protocols without manufacturer restrictions, allowing laboratories to use kits from any vendor. The AGILITY INTEGRA software module adds FDA 21 CFR Part 11-compliant audit trails, encrypted LIS connectivity, and secure networking to the high-throughput system, while proprietary consumables (SmartKit reagent packs, pipette tips, deep-well strips) and DS-Matrix / Co-Connect software complete the workflow stack.

Dynex generates revenue through three streams: (1) capital-equipment sales of DS2 ELITE, DSX, and AGILITY instruments, which are manufactured in the US and carry ISO 13485:2016, FDA, CE Mark, and IVDR certifications; (2) recurring consumables and proprietary reagent packs tied to the installed base of more than 8,500 instruments across 120+ countries; and (3) recurring service and maintenance subscriptions (Maintenance Plus, Preferred, Premium Plus, Enhanced Warranty) delivered by factory-trained field service engineers, complemented by professional assay-writing and training services. The company sells direct in the United States via a dedicated sales and customer-service organization and reaches international markets through vetted trained distributors, with a wholly-owned German subsidiary (DYNEX Technologies GmbH) anchoring European operations.

The customer base spans clinical diagnostic laboratories (hospitals and reference labs — the primary vertical), pharmaceutical and biotechnology research organizations (drug development, biomarker analysis), and specialty testing laboratories (veterinary, food safety, environmental). Recent strategic activity has centered on dual 2026 product launches (upgraded DS2 ELITE and AGILITY INTEGRA), a 2025 CEO transition to Lisa Miller (ex-Prometheus Laboratories, Dako, Thermo Fisher Scientific), and three named 2025 partnerships — with PROGEN (AAV9 gene-therapy assays), Tecan (immunoassay science collaboration), and ALPCO (chemiluminescence biomarker assays starting with GI). The company is led by a full VP-level bench covering Innovation, Operations, Global Quality & Regulatory Affairs, Global Commercial Business, Global HR, and IT & Security, with no disclosed outside funding, parent company, or public listing.

Name

Dynex Technologies

Legal name

Dynex Technologies, Inc.

Website

https://dynextechnologies.com

Company type

Private

Founded year

1950

Operating status

Operating

Headcount range

101–250 employees

Short description

Dynex Technologies, Inc. is a privately held US medical-device manufacturer founded in 1950 and headquartered in Chantilly, Virginia, that designs and sells fully automated ELISA and chemiluminescence microplate workstations (DS2 ELITE, DSX, AGILITY), proprietary consumables, and supporting software for clinical diagnostic, pharmaceutical research, and specialty testing laboratories worldwide.

Ownership category

akta.pro rank

Product category

Laboratory Diagnostic Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Surgical and Medical Instrument Manufacturing (339112)

SIC

Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841), Laboratory Apparatus & Furniture (3821)

akta.pro primary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

akta.pro secondary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Headquarters

HQ city

Chantilly

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. ELISA Instrumentation Sales: Sale of automated ELISA microplate instruments including DS2 ELITE, DSX, and AGILITY systems. Instruments are U.S.-manufactured and ISO-certified.
2. Consumables and Accessories: Sale of consumables specifically designed and verified for DYNEX instruments to ensure precise and accurate outcomes. Includes SmartKit reagent packs, pipette tips, and deep-well strips.
3. Service and Maintenance Plans: Factory-trained Field Service Engineers, Technical Support Specialists, and original manufacturer parts through service plans. Plans include Maintenance Plus, Preferred, Premium Plus, and Enhanced Warranty options.
4. Assay Writing Services: Professional assay writing services for developing custom protocols for unique testing needs on the open DYNEX platform.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Dynex Technologies designs, manufactures, and sells fully automated ELISA and chemiluminescence microplate workstations — the DS2 ELITE (2-plate), DSX (4-plate), and AGILITY (12-plate) systems — along with proprietary SmartKit reagent consumables, LIS integration and DS-Matrix software, and tiered maintenance/service plans. Its products serve clinical diagnostic laboratories, pharmaceutical and biotech researchers, and specialty testing labs (veterinary, food safety, environmental) needing open-platform immunoassay automation.

Product overview

Dynex Technologies offers a family of three fully automated ELISA microplate instruments—the DS2 ELITE (2-plate), DSX (4-plate), and AGILITY (12-plate)—designed for small, medium, and high-volume laboratories respectively. All systems feature open platform architecture supporting 1,000+ established assay protocols with no vendor restrictions. The AGILITY INTEGRA software module adds FDA 21 CFR Part 11 compliance to the AGILITY system. The portfolio also includes proprietary SmartKit reagent packs, Co-Connect and DS-Matrix software for LIS integration and workflow management, plus service offerings including assay writing, technical support, training, and comprehensive service plans.

Differentiator

Problem solved

Functional benefit

Products and services

• DS2 ELITE A 2-plate, fully automated ELISA microplate system designed for small to mid-sized laboratories. Features advanced LIS connectivity, tip verification technology, serial dilution capabilities, Co-Connect LIS interface, and Windows 11 compatibility in a compact footprint.
• DSX A 4-plate, fully automated ELISA microplate system designed for mid-volume laboratories. Offers walk-away automation, multiple assay processing simultaneously, and reagent pipetting volumes of 20–1000 μL with advanced flexibility at every workflow stage.
• AGILITY A 12-plate, high-throughput automated ELISA microplate system designed for high-volume laboratories. Features continuous sample loading, reduced hands-on time by up to 60%, processing of up to 200 samples with SmartKit reagent packs, and walk-away automation.
• AGILITY INTEGRA Software module for the AGILITY system that delivers FDA 21 CFR Part 11 compliance, improved audit trails, better LIS connectivity, secure networking, enhanced data encryption, and optimized reporting for regulated environments.
• SmartKit Reagent Packs Proprietary custom reagent packs designed and verified for the AGILITY system to minimize liquid transfers, reduce hands-on time, and provide better quality control with simplified loading.
• Co-Connect LIS Interface Software Stand-alone laboratory information system (LIS) interface software for the DS2 ELITE system that enables encrypted data transmission, seamless LIS integration, the ability to resend results, and simplified name mapping.
• DS-Matrix Software Proprietary software platform for the DS2 ELITE featuring assay editing, serial dilution, lot-specific data storage, modern user interface, user profiles with access-level controls, tip verification, and barcode scanning.
• Assay Writing Services Professional services to develop custom ELISA assay protocols for unique testing needs on the open DYNEX platform, available through service plans or as a separate offering.
• Service Plans (Maintenance Plus, Preferred, Premium Plus, Enhanced Warranty) Tiered annual maintenance and support plans including Maintenance Plus, Preferred, Premium Plus, and Enhanced Warranty, providing preventative maintenance, technical support, certified spare parts, labor/travel, consumables discounts, hardware upgrades, assay writing, and guaranteed on-site response times (up to 1 business day).
• Training Services Live training at customer facilities covering instrument mechanics, preventative maintenance, servicing, and application training for DYNEX systems, including the online MyDynex learning portal.

Quantifiable outcome

• Reduced hands-on time by up to 60%
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• PROGENcoreStrategic or Co-development PartnerDYNEX Technologies partnered with PROGEN to deliver advanced AAV9 assays on DYNEX's automated ELISA platforms. The partnership focuses on driving innovation and precision in therapeutic development, empowering customers with reliable, reproducible results in the rapidly evolving field of gene therapy.
• TecancoreStrategic or Co-development PartnerDYNEX Technologies and Tecan formed a collaborative partnership combining cutting-edge immunoassay science with trusted ELISA microplate technology. This partnership paves the way for advanced diagnostic solutions tailored specifically for the modern-day healthcare community.
• ALPCOcoreStrategic or Co-development PartnerDYNEX Technologies and ALPCO are combining the sensitivity and accuracy of traditional chemiluminescence sandwich immunoassays with the workflow advantages of automated multiplexing. The partnership provides a more complete biomarker testing solution within functional health, starting with GI biomarkers.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Bio-Rad Laboratories: Major life science and clinical diagnostics manufacturer with a long-standing ELISA and immunoassay instrumentation portfolio (e.g., Bio-Plex, EVOLIS). Directly competes with Dynex in the automated ELISA/microplate workflow space while also offering a far broader diagnostics and research reagents catalog.
• Roche Diagnostics: Dominant IVD manufacturer offering cobas and Elecsys immunoassay platforms that compete with ELISA-based testing in clinical labs. Represents the largest competitive threat as hospitals consolidate volume onto closed, fully automated Roche systems.
• Siemens Healthineers: Operates the ADVIA Centaur and Atellica immunoassay systems that substitute for ELISA-based testing in clinical labs. Comparable in serving hospital and reference-lab customers but at a substantially larger scale and with proprietary closed-system menus.
• PerkinElmer (Revvity): Provides a broad portfolio of life sciences and diagnostics instrumentation including immunoassay and ELISA automation capabilities. Comparable end customers and partially overlapping product lines in regulated clinical and research labs.
• Beckman Coulter Life Sciences: Provides automated immunoassay and sample-preparation workstations, ELISA processing solutions, and broader clinical diagnostics instruments. Competes with Dynex in clinical labs but at significantly larger scale and broader portfolio.
• Abbott Diagnostics: Architect and Alinity immunoassay platforms compete head-to-head with Dynex ELISA workstations in mid- and high-volume clinical labs. Comparable in clinical diagnostics end market but operates at much larger scale with closed reagent menus.

Direct peers

• Molecular Devices: Specializes in microplate readers, washers, and integrated ELISA workstations used in drug discovery and clinical research. Closely comparable to Dynex in microplate-based assay automation, with broader detection technology (absorbance, fluorescence, luminescence).
• Tecan: Swiss leader in laboratory automation and microplate-based instruments, including ELISA workstations and OEM platforms for IVD manufacturers. Tecan is also a current Dynex strategic partner, making it both a competitor and collaborator in automated ELISA.
• Hamilton Company: Manufactures automated liquid-handling workstations and ELISA processors (e.g., Microlab STAR) used in clinical diagnostics and life sciences. Direct overlap with Dynex's sample-prep and ELISA automation value proposition.

Emerging players

• Awareness Technology: Smaller, niche manufacturer of ELISA microplate readers, washers, and automated immunoassay instruments targeting clinical and research labs. Comparable to Dynex in scale and product focus, though with a more limited installed base.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dynex-technologies
• Xx.com/dynextech

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dynex Technologies